Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Breast Cancer
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Breast Cancer
Not yet recruiting · NCT07374796 · Registry updated 2026-09-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Breast Cancer | Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Not yet recruiting | Not stated | 2026-09-10 | NCT07374796 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| EPOCH Epigenetics, Inc | 3 |
| University of Maryland, Baltimore | 198 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Maryland Baltimore Washington Medical Center | Glen Burnie | United States | 4 |